$MCS

MARCUS CORP (MCS): Results of Operations and Financial Condition

MARCUS CORP (MCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mcs-2026730xex991.htm EX-99.1 Document Exhibit 99.1 MARCUS CORPORATION REPORTS SECOND QUARTER FISCAL 2026 RESULTS Marcus Corporation reports strong net earnings and highest revenue and Adjusted EBITDA in a second quarter since the pandemic; Marcus Theatres and Marcus Ho

Original reporting
Published Jul 30, 2026, 12:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 12:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MCS
Bullish
medium confidence
Mentioned
$MCS
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MCSBullishMed
01

Why it matters

The filing provides fresh, company-specific financial datapoints and segment performance commentary that can shift expectations for the remainder of FY2026.

02

Market read

A primary earnings disclosure with multiple upside YoY metrics and segment outperformance, likely to influence near-term positioning ahead of subsequent quarter updates.

03

What to watch

The excerpt does not include full guidance, cash flow details, leverage, or impairment/one-time items; traders should verify whether the outperformance is sustainable and whether margins/working capital improved.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (2026-07-30) with Q2 FY2026 results

Background

SEC Form 8-K Item 2.02 reporting Marcus Corporation’s second quarter fiscal 2026 results ended June 30, 2026.

Company-level read

Ticker impact

$MCSBullishMedium confidence
Context

Marcus Corporation reported Q2 FY2026 results with revenues up 12.5% to $231.7M and net earnings up 116.4% to $15.8M.

Expected impact

Likely positive bias for the stock as traders re-rate near-term fundamentals, though magnitude depends on prior expectations and any guidance not shown here.

Evidence & confidence

This is a primary earnings release via SEC 8-K with multiple upside year-over-year operating metrics (operating income, net earnings, Adjusted EBITDA) and segment outperformance, which typically drives incremental demand from earnings-focused flows.

Market effects

Reinforces demand resilience in leisure entertainment and upscale lodging, potentially supporting sentiment for other cinema and hotel operators.

Limited direct regional read-through; performance is described as national across hotels and theatre markets.

Low global relevance; story is primarily US leisure and consumer discretionary demand.

Counterpoint

Strong reported growth may be partly influenced by operating-day changes from the fiscal-year transition and by film slate timing, which can reverse in subsequent quarters.

Key entities

  • Marcus Corporation

    Reports Q2 FY2026 results with higher revenues, operating income, net earnings, and Adjusted EBITDA, citing outperformance in Theatres and Hotels & Resorts.

  • Marcus Theatres

    Reports total theatre revenues of $150.6M (+14.4% YoY) and same-store admission revenue +16.6% YoY.

  • Marcus Hotels & Resorts

    Reports record second quarter revenue and Adjusted EBITDA, with RevPAR up 13.9% at company-owned hotels (per excerpt).

Related articles

$MCSMed

Marcus Corp Q2 Profit Rises; Shares Climb

Marcus Corp. (MCS) reported Q2 results with net earnings up 116.4% to $15.84M, or $0.51/share, and operating income rising to $27.07M from $13.01M. Adjusted EBITDA increased 43% to $46.2M. Total revenue grew 12.5% to $231.74M. Shares were up about 8.7% at $27.14, per NYSE.

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.

$GRNDMedAI 8/10

Grindr CEO makes stunning AI reveal that changes the dating game

Grindr CEO George Arison said the dating app is shifting to an AI-native approach, using AI coding tools and expecting AI token costs of about $6 million this year. In Q2, Grindr reported revenue of $138 million, up 33% year over year, beating an estimated $132 million, with paying users up 16% to 1.4 million. Full-year 2026 guidance was raised to about $540 million revenue and $232 million adjusted EBITDA.

$MATVMed

Mativ Q2 Earnings Call Highlights

Mativ (NYSE:MATV) reported Q2 adjusted EBITDA of $50 million, up more than 18%, and segment margin up 210 bps to 15.3% as pricing offset inflation. Healthcare operations at its Knoxville facility normalized after an outage. Net debt fell to $908 million and net leverage improved to 3.8x. A Menasha, Wisconsin tornado is expected to cut Q3 sales by $20M to $25M.

$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.

$LTMMedAI 8/10

LATAM Airlines Group Q2 Earnings Call Highlights

LATAM Airlines Group reported Q2 net income of $125 million and adjusted operating cash flow of $476 million, with nearly $150 million positive cash change before dividends. The company said premium revenue was 29% of passenger revenue and LATAM Pass generated over 67% of passenger revenue. It reinstated 2026 guidance: revenue $17.3B to $17.7B and adjusted EBITDA $4.1B to $4.4B, plus 9% to 10% capacity growth.